{"id":"formylsulfamethin","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"wometin","offLabel":[],"synonyms":["formylsulfamethin","formylsulfamethine","formylsulfisomidine","wometin"],"timeline":[],"approvals":[],"brandName":"Wometin","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells are like factories, and enzymes are the workers that help them run smoothly. Wometin is like a tool that blocks one of these workers, causing the factory to slow down or stop producing a certain product. This can help to treat diseases caused by an overactive or malfunctioning factory.","oneSentence":"Wometin works by binding to and inhibiting a specific enzyme or protein, disrupting its normal function and leading to a therapeutic effect.","technicalDetail":"Wometin is a small molecule inhibitor that likely targets a specific enzyme or protein, potentially through competitive inhibition or allosteric modulation, to produce its therapeutic effect."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3247","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=formylsulfamethin","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:35:59.837641","biosimilars":[],"competitors":[],"genericName":"formylsulfamethin","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"0YCK79954S","CHEBI":"CHEBI:135301","PUBCHEM_CID":"617853"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Wometin, also known as formylsulfamethin, is a small molecule compound with unknown target and drug class. Its commercial status is unclear, and it is not FDA approved for any indications. As a small molecule, it is likely to work by interacting with specific biological molecules to produce a therapeutic effect. However, without more information, it is difficult to provide a comprehensive summary of its use and safety considerations. Further research is needed to determine its potential as a therapeutic agent.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}